glp-1 gip What is and GIP? Dual-action weight loss (UK) Targeting GLP-1, GIP & GCG
Description
Rapid or extreme weight loss over a short timeframe can lead to saggy or loose skin in some people
investigated the synergistic effects of MSTN inhibitors and GLP-1 agonists by administering apitegromab in combination with semaglutide, a GLP-1 agonist, and tirzepatide, a dual agonist of GLP-1 and glucose-dependent insulinotropic polypeptide, in patients with obesity (NCT06445075)
Gaede P, Vedel P, Larsen N, et al
Glucagon receptor signaling regulates energy metabolism via hepatic farnesoid X receptor and fibroblast growth factor 21
Ozempic is approved for type 2 diabetes, while Wegovy is specifically approved for weight loss
